Literature DB >> 9548416

Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice.

M Pospísil1, M Hofer, V Znojil, J Netíková, J Vácha, J Holá, A Vacek.   

Abstract

The activation of adenosine receptors has recently been demonstrated to stimulate haematopoiesis. In the present study, we investigated the ability of drugs elevating extracellular adenosine to influence curative effects of granulocyte colony-stimulating factor (G-CSF) in mice exposed to a sublethal dose of 4 Gy of 60Co radiation. Elevation of extracellular adenosine in mice was induced by the combined administration of dipyridamole, a drug inhibiting the cellular uptake of adenosine, and adenosine monophosphate (AMP), an adenosine prodrug. The effects of dipyridamole plus AMP, and G-CSF, administered either alone or in combination, were evaluated. The drugs were injected to mice in a 4-d treatment regimen starting on d 3 after irradiation and the haematopoietic response was evaluated on d 7, 10, 14, 18 and 24 after irradiation. While the effects of G-CSF on the late maturation stages of blood cells, appearing shortly after the completion of the treatment, were not influenced by dipyridamole plus AMP, positive effects of the combination therapy occurred in the post-irradiation recovery phase which is dependent on the repopulation of haematopoietic stem cells. This was indicated by the significant elevation of counts of granulocyte-macrophage progenitor cells (GM-CFC) and granulocytic cells in the bone marrow (d 14), of GM-CFC (d 14), granulocytic and erythroid cells (d 14 and 18) in the spleen, and of neutrophils (d 18), monocytes (d 14 and 18) and platelets (d 18) in the peripheral blood. These effects suggest that the repopulation potential of the combination therapy lies in a common multilineage cell population. The results of this study implicate the promising possibility to enhance the curative effects of G-CSF under conditions of myelosuppressive states induced by radiation exposure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548416     DOI: 10.1111/j.1600-0609.1998.tb01019.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters.

Authors:  Michal Hofer; Milan Pospíšil; Ladislav Dušek; Zuzana Hoferová; Denisa Komůrková
Journal:  Purinergic Signal       Date:  2014-04-25       Impact factor: 3.765

2.  T lymphocytes and normal tissue responses to radiation.

Authors:  Dörthe Schaue; William H McBride
Journal:  Front Oncol       Date:  2012-09-19       Impact factor: 6.244

3.  A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.

Authors:  Shira Cohen; Faina Barer; Sara Bar-Yehuda; Adriaan P IJzerman; Kenneth A Jacobson; Pnina Fishman
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

4.  A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate.

Authors:  Anders Lindholm Sørensen; Klaus Kallenbach; Hans Carl Hasselbalch
Journal:  Leuk Res Rep       Date:  2016-06-27

Review 5.  Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.

Authors:  Michal Hofer; Zuzana Hoferová; Daniel Depeš; Martin Falk
Journal:  Molecules       Date:  2017-05-19       Impact factor: 4.411

Review 6.  The role of adenosine receptor agonists in regulation of hematopoiesis.

Authors:  Michal Hofer; Milan Pospisil; Lenka Weiterova; Zuzana Hoferova
Journal:  Molecules       Date:  2011-01-17       Impact factor: 4.411

7.  Regulatory T cells in radiotherapeutic responses.

Authors:  Dörthe Schaue; Michael W Xie; Josephine A Ratikan; William H McBride
Journal:  Front Oncol       Date:  2012-08-17       Impact factor: 6.244

8.  Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.

Authors:  G Ohana; S Bar-Yehuda; A Arich; L Madi; Z Dreznick; L Rath-Wolfson; D Silberman; G Slosman; P Fishman
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.